Assessment of effective dose to staff in brachytherapy.
The aim of this paper is to investigate the problem of monitoring effective dose to hospital staff who are involved in the treatment of tumors using sealed sources placed inside the body (brachytherapy). In addition, the use of an unsealed source to treat the thyroid was also considered. Radiation distributions produced by both sealed sources commonly used in brachytherapy (192I, 137Cs, 226Ra) and an unsealed source used in the treatment of the thyroid (131I) were used to irradiate a Rando phantom. The brachytherapy treatments of esophageal and gynecological carcinoma were simulated. The Rando phantom was loaded with lithium fluoride thermoluminescent dosimeters at positions corresponding to a number of radiosensitive organs. Film badges and electronic personal dosimeters were attached to the Rando phantom at various anatomical sites. The Rando phantom was positioned adjacent to the patient at an angle of 90 degrees to the longitudinal axis of the patient. Irradiations were performed with and without a portable lead screen used on the radiotherapy wards. Effective dose was estimated for each simulated radiotherapy treatment and compared with the personal monitor readings. The data were used as a basis for the provision of advice on the wearing of the film badge dosimeters and the design of portable lead screens. The data also permitted a comparison between the two types of dosimeter when used for personal monitoring in brachytherapy.
Faulkner
K
K
Regional Medical Physics Department, Newcastle General Hospital, Newcastle upon Tyne, United Kingdom.
James
H V
HV
Chapple
C L
CL
Rawlings
D J
DJ
D001918:Brachytherapy / Q000379:methods*; D004307:Dose-Response Relationship, Radiation; D005260:Female; D005373:Film Dosimetry; D006801:Humans; D008505:Medical Staff, Hospital; D008961:Models, Structural; D016273:Occupational Exposure; D011247:Pregnancy; D011829:Radiation Dosage; D011834:Radiation Monitoring / Q000379:methods*; D014018:Tissue Distribution